NICE Committee Meeting to Review the Possibility of Recommending that Access to the Treatment Zolgensma is Funded by the NHS Delayed

06 January 2020

AveXis have advised NICE of an update to their regulatory timings. NICE advised therefore, on 23rd December, that the first committee discussion scheduled to take place on Thursday 26 March will not now take place.

The evaluation will be rescheduled into the work programme and the updated timelines will be communicated, once known.